SCHEMBL8930906

SCHEMBL8930906

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3c2nc(-c2ccccc2)n3-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 1/20 0.46
▸ PI4K2B Q8TCG2 1/20 0.46
▸ PI4K2A Q9BTU6 1/20 0.46
▸ PI4KB Q9UBF8 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ HCAR1 Q9BXC0 1/20 0.39
▸ AVPR1A P37288 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930946 0.97 KMT2A (0.46) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930908 0.89 PI4KA (0.39) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930977 0.89 PI4KA (0.37) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930936 0.88 ESR1 (0.54) ALDH1A1KMT2AMEN1HSP90AA1MAPT
SCHEMBL8930903 0.87 PI4KA (0.39) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930967 0.87 PI4KA (0.37) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL28979811 0.87 PI4KA (0.48) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930912 0.86 MEN1 (0.40) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930939 0.85 MAPT (0.45) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL8930942 0.84 ESR2 (0.50) ALDH1A1TSHRKMT2AMEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-8187727-B2 Imidazole derivatives, preparation method thereof and organic electronic device using the same LG CHEM, LTD. (KR) 2012-05-29 — — US disclosed
US-8187727-B2 Imidazole derivatives, preparation method thereof and organic electronic device using the same LG CHEM, LTD. (KR) 2012-05-29 — — US disclosed
US-20110024736-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY SONY CORPORATION (JP) 2011-02-03 — — US disclosed
US-20110024736-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY SONY CORPORATION (JP) 2011-02-03 — — US disclosed
US-20070018155-A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same LG CHEM. LTD. (KR) 2007-01-25 — — US disclosed
US-20070018155-A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same LG CHEM. LTD. (KR) 2007-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070018155-A1 New imidazole derivatives, preparation method thereof and organic electronic device using the same ICMT, TIMM9, TIMM44 PI4KA 407/4885PI4K2B 694/4885PI4K2A 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback